Med-Aesthetic Solutions, Inc. – Trademark Portfolio
Entity Type: 03
Med-Aesthetic Solutions, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SALTFACIAL and SALTFACIAL L'AVANTAGE. The owner is based in Cardiff, CA.
2033 San Elijo Ave.
Cardiff, CA 92007
Showing of trademarks Trademarks
Trademark Classifications
Med-Aesthetic Solutions, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Med-Aesthetic Solutions, Inc. have?
Med-Aesthetic Solutions, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 1 cancelled.
What trademark classes does Med-Aesthetic Solutions, Inc. file in?
Med-Aesthetic Solutions, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Med-Aesthetic Solutions, Inc.'s most well-known trademarks?
Med-Aesthetic Solutions, Inc.'s registered trademark portfolio includes well-known marks such as SALTFACIAL and SALTFACIAL L'AVANTAGE. These are among 2 currently registered trademarks in the portfolio.
What is Med-Aesthetic Solutions, Inc.'s trademark registration success rate?
Med-Aesthetic Solutions, Inc. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.